State Treasurer Denise L. Nappier today announced that Amgen Inc. has agreed to pay $95 million to settle a class action suit filed on behalf of investors who bought Amgen securities between April 2004 and May 2007. “As lead plaintiff, we have diligently pursued this action for nearly a decade. This settlement will assist institutional and …
When Connecticut State Treasurer Denise Nappier announced Wednesday that the state retirement fund, as the lead plaintiff in a securities class action against the biotech company Amgen, had settled the case for $95 million, I was startled to realize the litigation was still going on. It’s been a while, after all. Investors first sued Amgen all the way back in 2007 for (among other …
Amgen Inc. will pay $95 million to settle a class action lawsuit, the company announced Wednesday. The suit was filed on behalf of shareholders who purchased Amgen stock from April 22, 2004 through May 10, 2007 and sought to recover damages for certain statements made by the Thousand Oaks biotech. Amgen believes the lawsuit has no merit and emphasizes the settlement is not an admission of guilt …